Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.10.0.1
Note 14 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenues $ 7,557,000 $ 6,000,000 $ 14,655,000 $ 11,507,000
Operating income (loss) (100,402) (995,526) (539,466) (2,700,835)
Depreciation and amortization 404,975 503,226 792,392 1,081,212
Bargain purchase gain 75,264 75,264
Other (expense) income, net (11,689) (24,031) (22,884) (43,496)
Loss before income tax expense (36,827) (1,019,557) (487,086) (2,744,331)
Operating Segments [Member]        
Operating income (loss) 1,888,000 1,007,000 3,814,000 1,223,000
Corporate, Non-Segment [Member]        
Operating income (loss) (1,989,000) (2,003,000) (4,353,000) (3,924,000)
Corporate Clinics [Member]        
Revenues 3,421,000 2,680,000 6,677,000 5,176,000
Operating income (loss) (86,000) (438,000) 25,000 (1,455,000)
Depreciation and amortization 245,000 400,000 548,000 844,000
Franchise Operations [Member]        
Revenues 4,136,000 3,320,000 7,978,000 6,331,000
Operating income (loss) 1,974,000 1,445,000 3,789,000 2,678,000
Depreciation and amortization
Corporate Segment [Member]        
Depreciation and amortization $ 160,000 $ 103,000 $ 244,000 $ 237,000